Session » Health Services Research Poster I – ACR/ARHP

Date: Sunday, October 21, 2018

Time: 9:00AM-11:00AM

Meeting: 2018 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 299

A Comparison of Persistent Versus Limited Frequent Emergency Department (ED) Utilization Among Systemic Lupus Erythematosus (SLE) Patients

9:00AM-11:00AM: Abstract Number: 289

Adherence of Etanercept in Iraqi Patients with Rheumatoid Arthritis: One- and Five-Year Data from a Local Registry

9:00AM-11:00AM: Abstract Number: 283

Benefits Accrued through the Implementation of Telerheumatology Services

9:00AM-11:00AM: Abstract Number: 300

Built-in-Electronic-Medical-Record Disease Activity Calculators and Treat-to-Target in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 288

Burden of Illness of Treating Patients with Pemphigus vulgaris

9:00AM-11:00AM: Abstract Number: 284

Challenges and Barriers to Employment That Persons with Osteoarthritis Face at Work Due to Their Condition

9:00AM-11:00AM: Abstract Number: 287

Comparison of Real-World Costs between Patients with Rheumatoid Arthritis Treated with Subcutaneously-Administered Biologics Previously Treated with Another Biologic

9:00AM-11:00AM: Abstract Number: 292

Derivation of a National Rheumatoid Arthritis Cohort in the Veterans Health Administration and Validation with the Veterans Affairs Rheumatoid Arthritis Registry

9:00AM-11:00AM: Abstract Number: 296

Does Care By a Multidisciplinary Team Improve Outcomes in Rheumatoid Arthritis? a Randomized Controlled Study

9:00AM-11:00AM: Abstract Number: 290

Emergency Department (ED) Utilization Among SLE Patients and Controls in the Population-Based Michigan Lupus Epidemiology & Surveillance (MILES) Cohort

9:00AM-11:00AM: Abstract Number: 298

Factors Affecting Inpatient Mortality in Hospitalizations for Sepsis with Underlying Systemic Lupus Erythematosus: Data from the National Inpatient Sample 2010-2014

9:00AM-11:00AM: Abstract Number: 291

Factors Associated with High-Dose Corticosteroid Use in SLE Patients Post Initiation of SLE Therapy

9:00AM-11:00AM: Abstract Number: 297

Hospitalization Rates Among Patients with Polymyalgia Rheumatica: A Population-Based Study from 1995-2017

9:00AM-11:00AM: Abstract Number: 295

Implementing a Staff Tobacco Cessation Protocol Increases Quit Line Referrals in a Community Rheumatology Practice

9:00AM-11:00AM: Abstract Number: 285

Inflammatory Bowel Disease Is Associated with a Substantial Economic Burden in Patients with Psoriatic Arthritis and in Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 294

Physical Therapists’ Ability to Recognize Inflammatory Arthritis Cases and Awareness of Importance for Their Prompt Referral to Rheumatology

9:00AM-11:00AM: Abstract Number: 301

Rheumatology Clinic Staff Needs for Partnering to Improve Blood Pressure and Tobacco Risk Management

9:00AM-11:00AM: Abstract Number: 293

Temporal Trends and Factors Associated with Bisphosphonate Drug Holidays

9:00AM-11:00AM: Abstract Number: 286

The Prevalence and Treatment Patterns of Women of Childbearing Age with Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 282

The Utility of Positive ANA Referrals at the University of Chicago

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].